Rituximab for refractory autoimmune hepatitis: A case report

Arab Journal of Gastroenterology

Volumn 14, Issue 3, 2013, Pages 135-138

  Al Busafi, Said A ^a,b   Michel, René P ^c   Deschenes, Marc ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Auto immune; Hepatitis; Rituximab

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM CARBONATE; CANDESARTAN; PREDNISONE; RITUXIMAB; VITAMIN D;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CASE REPORT; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; JAUNDICE; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA; WEIGHT REDUCTION;

AUTO-IMMUNE; HEPATITIS; RITUXIMAB;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOLOGIC FACTORS; PREDNISONE; TREATMENT FAILURE;

EID: 84886293039     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2013.08.009     Document Type: Article

References (20)

1. Feld J.J., et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005, 42(1):53-62.
2. Ichai P., et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007, 13(7):996-1003.
3. Alvarez F., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31(5):929-938.
4. Vergani D., et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group. J Hepatol 2004, 41(4):677-683.
5. Al-Chalabi T., et al. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 2008, 48(1):140-147.
6. Czaja A.J., Rakela J., Ludwig J. Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 1988, 95(2):448-453.
7. Montano-Loza A.J., Carpenter H.A., Czaja A.J. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 2007, 46(4):1138-1145.
8. Manns M.P., et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010, 51(6):2193-2213.
9. Gurcan H.M., et al. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 2009, 9(1):10-25.
10. Santos E.S., et al. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature. Liver Int 2006, 26(5):625-629.
11. Barth E., Clawson J. A case of autoimmune hepatitis treated with rituximab. Case Rep Gastroenterol 2010, 4(3):502-509.
12. Dalle S., Dumontet C. Rituximab: mechanism of action and resistance. Bull Cancer 2007, 94(2):198-202.
13. Verma S., Torbenson M., Thuluvath P.J. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology 2007, 46(6):1828-1835.
14. Fainboim L., et al. Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype. Hum Immunol 1994, 41(2):146-150.
15. Gregorio G.V., et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997, 25(3):541-547.
16. Verslype C., et al. Diagnosis and treatment of autoimmune hepatitis at age 65 and older. Aliment Pharmacol Ther 2005, 21(6):695-699.
17. Vergani D., et al. Pathogenesis of autoimmune hepatitis. Clin Liver Dis 2002, 6(3):727-737.
18. Dienes H.P., et al. Histologic features in autoimmune hepatitis. Z Gastroenterol 1989, 27(6):325-330.
19. McFarlane I.G. Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin Liver Dis 2002, 6(3):605-621.
20. Manns M.P., et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 2010, 139(4):1198-1206.